Akèy › Kansè poumon selil ti › Missouri › St. Louis
Etid klinik pou Kansè poumon selil ti nan St. Louis, MO
13 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Ap rekriteFaz 3
- Mercy South, St Louis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Ap rekriteFaz 3
- Washington University School of Medicine, St Louis
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Ap rekriteFaz 1/2
- WA Uni School Of Med, St Louis
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Ap rekriteFaz 1
- Washington University Medicine, St Louis
Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Ap rekriteFaz 1/2
- Washington University School of Medicine, St Louis
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Ap rekriteFaz 3
- Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
Ap rekriteFaz 1
- Washington University School of Medicine, St Louis
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Ap rekriteFaz 1/2
- Washington University School of Medicine (Siteman Cancer Center), St Louis
A Study of LY4175408 in Participants With Advanced Cancer
Ap rekriteFaz 1
- Washington University, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Ap rekriteFaz 2
- Siteman Cancer Center, Washington University, St Louis
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Ap rekriteFaz 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Washington University, St Louis
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Washington University, St Louis
Etid Kansè poumon selil ti nan lòt vil
- Houston, TX26 etid
- Arlington, VA23 etid
- New York City, NY22 etid
- Boston, MA21 etid
- Los Angeles, CA20 etid
- Nashville, TN20 etid
- Orlando, FL15 etid
- Dallas, TX13 etid
- Cleveland, OH13 etid
- Chicago, IL13 etid
- Detroit, MI12 etid
- Washington, DC12 etid
Lòt etid nan St. Louis
- Kansè Poumon ki pa ti selil73 etid
- Kansè nan tete64 etid
- Kansè Metastatik54 etid
- Kansè kolorektal50 etid
- Kansè (tout kalite)46 etid
- Kansè pwostat46 etid
- Kansè poumon39 etid
- Kansè ovè38 etid
- Kansè pankreyas33 etid
- Kansè Endomèt29 etid
- Karsinòm selil skuamèz tèt ak kou28 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.